Vistagen Therapeutics, Inc.
VTGN· Nasdaq
VTGNVistagen Therapeutics, Inc.
Filed Jun 25, 2014 · 10-K · 86 days after period end · 0001415889-14-001957
| Metric | Q4 2014 | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | — | $352.73K |
| Net Income | -$1.83M | -$3.54M |
| EPS Diluted | -$1.57 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vistagen Therapeutics, Inc. · CIK 1411685 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed Jun 25, 2014 · 86 d after period end
